Medtronic makes six tranche debut for €7bn in sweltering market

Medtronic patient medical device from co media gallery 230x150
By Jon Hay
04 Mar 2019

A chilly east wind may be reminding Londoners it’s only March, but an unseasonal summer continues to blaze in the corporate bond market. Medtronic, the US-Irish maker of high tech medical devices, made its debut in the currency today with a six tranche extravaganza that attracted over €30bn of demand.

All its tranches began trading bid about 2bp tighter than reoffer in the grey market, according to a banker away from the deal, except the 12 year tranche, which was 1bp tighter.

Bank of America Merrill Lynch and Barclays were bookrunners, bringing to fruition a roadshow they had ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.